Biotech
Xaira Therapeutics
Xaira Therapeutics raises $1B Series A at $4B valuation
San Francisco, CAApril 23, 20241 min read
Total Raised
$1B
Valuation
$4B
Latest Round
Series A
Employees
100+
Xaira Therapeutics: Series A Funding Round
Xaira Therapeutics has successfully raised $1B in Series A funding, reaching a valuation of $4B.
Company Overview
AI-powered drug discovery platform
Funding Details
The Series A round was led by Foresite Capital, with participation from ARCH Venture Partners, NEA.
Company Information
- Headquarters: San Francisco, CA
- Founded: 2023
- Employees: 100+
- Category: Biotech
Investment
Xaira Therapeutics plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Foresite Capital: Verified investor in Series A
- ARCH Venture Partners: Verified investor in Series A
- NEA: Verified investor in Series A
Company Info
Headquarters
San Francisco, CA
Founded
2023
Team Size
100+
Last Round
$1B(Apr 2024)
Investors (3)
F
Foresite CapitalLeadLead Investor
Verified investor in Series A
A
ARCH Venture PartnersInvestor
Verified investor in Series A
N
NEAInvestor
Verified investor in Series A
Share
Related Reports
Biotech
AusperBio
AusperBio Raises $73M Series B
Biotech company developing AHB-137, an antisense oligonucleotide for chronic hepatitis B treatment entering phase 2 trials
David Chen
Dec 30, 2025
0 min read•$73M Series B
Biotech
Orna Therapeutics
Orna Therapeutics Raises $251M Series B
Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases
Emma Rodriguez
Oct 23, 2025
0 min read•$251M Series B
Biotech
Forge Biologics
Forge Biologics Raises $120M Series C
Gene therapy CDMO providing manufacturing and development services for AAV-based genetic medicines
Sarah Kim
Oct 23, 2025
0 min read•$120M Series C
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free